Novacyt S.A. (AIM:NCYT)
London · Delayed Price · Currency is GBP · Price in GBX 34.90
+0.10 (0.29%)
Jan 23, 2026, 4:56 PM GMT
Novacyt Market Cap
Novacyt has a market cap or net worth of 24.79 million as of January 23, 2026. Its market cap has decreased by -39.16% in one year.
Market Cap
24.79M
Enterprise Value
11.89M
Revenue
19.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.90
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 18.97M to 24.79M, an increase of 30.70%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 24.79M | 3.09% |
| Dec 31, 2025 | 24.05M | -31.52% |
| Dec 31, 2024 | 35.12M | -19.57% |
| Dec 29, 2023 | 43.67M | -43.27% |
| Dec 30, 2022 | 76.97M | -70.37% |
| Dec 31, 2021 | 259.78M | -58.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.61B |
| GSK plc | 72.26B |
| Haleon | 33.83B |
| Smith & Nephew | 10.41B |
| Poolbeg Pharma | 29.63M |
| Renalytix | 27.31M |
| Sareum Holdings | 26.92M |
| Abingdon Health | 26.00M |